Precigen, Inc. - Common Stock (NQ:PGEN)

8.540 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Precigen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Morgan Stanley, Charles Schwab, Bank of America, And Other Big Stocks Moving Higher On Tuesday ↗

July 18, 2023

U.S. stocks traded mostly higher, with the Dow Jones gaining over 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

The Immunotherapy Market Is Expected To Surpass $351.56 Billion By 2030 – Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) Is Contributing to This Growth ↗

July 12, 2023

Immunotherapy, in general, is an exciting and growing sector in the pharmaceutical industry. It involves manipulating the human body's immune system to treat various diseases. While historically this...

Via Benzinga

Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 12, 2023

Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord.

Via Benzinga

Recap: Precigen Q1 Earnings ↗

May 10, 2023

Via Benzinga

Precigen Regains Rights To CAR-T Platform For Hematological, Solid Tumor Indications ↗

April 04, 2023

Via Benzinga

New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action

June 08, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – June 8, 2023 – USA News Group – By utilizing newly developed novel mechanisms, biotech researchers and scientists are making...

Via FinancialNewsMedia

3 Penny Stocks That Could Skyrocket in the Next 12 Months ↗

June 07, 2023

Find the top penny stocks to buy, and you can make a fortune. Pick the wrong one and there are also plenty of horrors.

Via InvestorPlace

Precigen Touts Encouraging Data From Autologous UltraCAR-T Cells Manufactured Overnight For Next Day Infusion In Ovarian Cancer ↗

June 06, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023 ↗

May 23, 2023

Via Benzinga

Precigen's Return On Capital Employed Insights ↗

March 09, 2023

Via Benzinga

Earnings Preview For Precigen ↗

March 03, 2023

Via Benzinga

Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich … or Broke. ↗

May 19, 2023

Explore the world of high-risk penny stocks, with their potential for significant returns, as we analyze three speculative opportunities.

Via InvestorPlace

7 High-Potential Penny Stocks in the Biotech Sector ↗

May 04, 2023

Most of the biggest biotech stocks on the market started off as unknown penny stocks. Here are seven hot ones to consider.

Via InvestorPlace

3 High-Growth Biotech Stocks Poised for Success in 2023 ↗

April 18, 2023

If you look for growth opportunities wherever you can find them, there are some high-growth biotech stocks that could present an opportunity

Via InvestorPlace

3 Healthcare Stocks Insiders Are Buying

April 13, 2023

The healthcare industry is looking forward to double-digit growth, and these stocks the insiders are buying have analyst support too.

Via MarketBeat

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 23, 2023

Via Benzinga

2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years ↗

March 17, 2023

Biotechs are capable of making huge gains in short periods, and they often do.

Via The Motley Fool

Founders at These 7 Companies Are Loading Up on Their Stock. Should You? ↗

March 15, 2023

Insiders sell for all kinds of reasons. There’s only one reason for insider buying. These seven founders and CEOs are loading up.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 03, 2023

We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on!

Via InvestorPlace

3 Penny Stocks The Insiders Are Buying

February 28, 2023

The insiders are buying these penny stocks with support from analysts and institutions. Could they be the next big winners?

Via MarketBeat

Topics Intellectual Property

Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week ↗

February 16, 2023

Concerns about a tough financing environment weighed on clinical-stage biotech stocks this week.

Via The Motley Fool

Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response ↗

February 07, 2023

New hope may be on the horizon for sufferers of Recurrent Respiratory Papillomatosis, or RRP, a rare and debilitating disease that typically requires patients to undergo multiple surgeries each year to...

Via Benzinga

Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response

February 07, 2023

Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response

Via News Direct

$20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying ↗

February 01, 2023

The Dow Jones jumped more than 350 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About ↗

January 26, 2023

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. Retail traders have countless methods at their disposal to uncover new information. For some, this...

Via Benzinga

Nasdaq Falls 50 Points; eHealth Shares Spike Higher ↗

January 25, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 50 points on Wednesday. The Dow traded down 0.12% to 33,694.64 while the NASDAQ fell 0.44% to 11,284.18....

Via Benzinga

Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 25, 2023

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.

Via Benzinga

Nasdaq Down Over 200 Points; AT&T Posts Upbeat Earnings ↗

January 25, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Wednesday. The Dow traded down 1.10% to 33,364.09 while the NASDAQ fell 1.92% to 11,116.96....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 25, 2023

Via Benzinga

US Stocks Open Lower; Dow Dips 250 Points ↗

January 25, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.74% to 33,484.47 while the NASDAQ fell...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.